Gland Pharma
NSEI:GLAND
Rp 1.710,50
Rp0,00 (0,00%)
1.710,50 Rp
Rp0,00 (0,00%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

Rp42,40
Earnings Per Share
Rp340,89
Revenue Per Share
56,16%
Gross Margin %
Rp281,82 B
Market Cap
Rp0,78 B
Long-Term Debt
Earnings Per Share
Rp42,40
Revenue Per Share
Rp340,89
Gross Margin %
56,16%
Market Cap
Rp281,82 B
Long-Term Debt
Rp0,78 B

Financials

Year Year 2025 2024 2023 2022 2021
EPS Earnings Per Share Rp42,40 Rp46,89 Rp49,97 Rp73,64 Rp62,99
Earnings Earnings Rp6,99B Rp7,72B Rp8,23B Rp12,10B Rp10,30B
RPS Revenue Per Share Rp340,89 Rp343,92 Rp220,07 Rp267,85 Rp211,68
Revenue Revenue Rp56,17B Rp56,65B Rp36,25B Rp44,01B Rp34,63B
OCF Operating Cash Flow Rp9,15B Rp9,97B Rp3,64B Rp7,91B Rp6,05B
FCF Free Cash Flow Rp5,30B Rp6,07B Rp1,43B Rp2,80B Rp3,76B
OM Operating Margin 15,53% 17,45% 24,40% 31,81% 34,75%
GM % Gross Margin % 56,16% 54,92% 48,70% 48,89% 53,52%
FCFS Free Cash Flow Per Share Rp31,60 Rp36,34 Rp8,56 Rp16,37 Rp23,80
LT Debt Long-Term Debt Rp776,64M Rp1,07B Rp32,61M Rp38,21M Rp39,34M
Sha. Stocks 164,76M 164,71M 164,7M 164,3M 163,59M
×